1-[5-[[5-fluoro-4-(2-pyrrolidin-1-ylquinazolin-6-yl)pyrimidin-2-yl]amino]-2-pyridinyl]piperidin-4-ol
C26H27FN8O — CID 169265951
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[5-[[5-fluoro-4-(2-pyrrolidin-1-ylquinazolin-6-yl)pyrimidin-2-yl]amino]-2-pyridinyl]piperidin-4-ol
1-[5-[[5-fluoro-4-(2-pyrrolidin-1-ylquinazolin-6-yl)pyrimidin-2-yl]amino]-2-pyridinyl]piperidin-4-ol (PubChem CID 169265951) has the molecular formula C26H27FN8O and a molecular weight of 486.56 g/mol. Its IUPAC name is 1-[5-[[5-fluoro-4-(2-pyrrolidin-1-ylquinazolin-6-yl)pyrimidin-2-yl]amino]-2-pyridinyl]piperidin-4-ol.
Molecular Properties
| Compound Name | 1-[5-[[5-fluoro-4-(2-pyrrolidin-1-ylquinazolin-6-yl)pyrimidin-2-yl]amino]-2-pyridinyl]piperidin-4-ol |
|---|---|
| PubChem CID | 169265951 |
| Molecular Formula | C26H27FN8O |
| Molecular Weight | 486.56 g/mol |
| Exact Mass | 486.23 |
| IUPAC Name | 1-[5-[[5-fluoro-4-(2-pyrrolidin-1-ylquinazolin-6-yl)pyrimidin-2-yl]amino]-2-pyridinyl]piperidin-4-ol |
| SMILES | OC1CCN(c2ccc(Nc3ncc(F)c(-c4ccc5nc(N6CCCC6)ncc5c4)n3)cn2)CC1 |
| InChI | InChI=1S/C26H27FN8O/c27-21-16-29-25(31-19-4-6-23(28-15-19)34-11-7-20(36)8-12-34)33-24(21)17-3-5-22-18(13-17)14-30-26(32-22)35-9-1-2-10-35/h3-6,13-16,20,36H,1-2,7-12H2,(H,29,31,33) |
| InChIKey | UVLQUENEHULXBT-UHFFFAOYSA-N |
| XLogP | 3.93 |
| TPSA | 103.19 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 486.56 |
| LogP ≤ 5 | 3.93 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 169265951 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.